摘要
目的观察痰热清注射液治疗流感病毒A、流感病毒B、腺病毒急性上呼吸道感染的临床疗效。方法发热性上呼吸道病毒感染85例,随机分成痰热清注射液组和病毒唑注射液组。结果其中流感A71例,流感B10例,腺病毒4例。运用痰热清注射液治疗总有效率为79.1%,病毒唑注射液治疗总有效率为45.2%,(P<0.05)。结论痰热清注射液组治疗流感病毒A、流感病毒B、腺病毒急性上呼吸道感染疗效较满意。
Objective To investigate the therapeutic effect of Tanreqing injection （TRQI） on acute upper respiratory tract infection induced by viruses. Methods Eighty five cases with acute febrile upper respiratory tract infection were randomly divided into two groups, with the cases in treating group（TG） treated by TRQI and those in controlling one（CG） treated by virazole injection（VRZI）. Their etiological diagnosis was established based on the data of serum virological test with ELISA. Results Among these cases, 71 were infected with influenza A virus, 10 were infected with influenza B virus, and 4 were with adenovirus infection. The total effective rate among the cases of TG was 79.1% and it was 45.2 % among the cases of CG, with a significantly statistic difference between the two groups （P 〈 0.05）. Conclusion TRQI is effective for the treatment of acute febrile upper respiratory tract infection induced by influenza A virus, influenza B virus or adenovirus.
出处
《中国中西医结合耳鼻咽喉科杂志》
2006年第3期171-173,共3页
Chinese Journal of Otorhinolaryngology in Integrative Medicine
关键词
痰热清注射液
急性上呼吸道感染
病毒
疗效
Tanreqing Injection
Acute upper respiratory tract infection
Virus
Therapeutic effect
